Connors Investor Services’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-172,043
Closed -$3.03M 153
2019
Q1
$3.03M Buy
172,043
+674
+0.4% +$11.2K 0.41% 59
2018
Q4
$2.98M Sell
171,369
-1,755
-1% -$29.9K 0.46% 51
2018
Q3
$2.58M Sell
173,124
-5,859
-3% -$90.8K 0.35% 75
2018
Q2
$2.85M Sell
178,983
-8,182
-4% -$122K 0.4% 75
2018
Q1
$2.66M Sell
187,165
-9,341
-5% -$138K 0.39% 72
2017
Q4
$2.75M Sell
196,506
-5,346
-3% -$78.3K 0.4% 67
2017
Q3
$2.89M Sell
201,852
-2,932
-1% -$41.9K 0.44% 63
2017
Q2
$3.23M Sell
204,784
-13,648
-6% -$197K 0.51% 58
2017
Q1
$3.01M Buy
218,432
+77,346
+55% +$1.08M 0.5% 57
2016
Q4
$2.5M Sell
141,086
-9,466
-6% -$166K 0.43% 65
2016
Q3
$2.9M Sell
150,552
-309
-0.2% -$6.05K 0.51% 54
2016
Q2
$2.94M Sell
150,861
-1,084
-0.7% -$21.3K 0.57% 51
2016
Q1
$3.13M Buy
151,945
+397
+0.3% +$7.82K 0.62% 52
2015
Q4
$3.11M Sell
151,548
-65
-0% -$1.25K 0.63% 54
2015
Q3
$2.59M Sell
151,613
-3,309
-2% -$60.5K 0.59% 55
2015
Q2
$2.85M Sell
154,922
-1,320
-0.8% -$24.5K 0.59% 61
2015
Q1
$2.98M Buy
156,242
+2,424
+2% +$44.8K 0.64% 55
2014
Q4
$2.53M Buy
153,818
+44,850
+41% +$769K 0.58% 63
2014
Q3
$1.93M Buy
108,968
+353
+0.3% +$6.93K 0.47% 75
2014
Q2
$2.24M Sell
108,615
-91
-0.1% -$1.87K 0.53% 68
2014
Q1
$2.37M Sell
108,706
-734
-0.7% -$16.8K 0.57% 68
2013
Q4
$2.9M Sell
109,440
-9,128
-8% -$224K 0.72% 55
2013
Q3
$2.8M Sell
118,568
-10,022
-8% -$234K 0.79% 51
2013
Q2
$2.77M Buy
+128,590
New +$2.77M 0.89% 45

Other funds holding VIVO

Connors Investor Services's VIVO Position: Q2 2019 in Review

Connors Investor Services sold out of Meridian Bioscience Inc (VIVO) in Q2 2019, closing a stake of 172,043 shares — an estimated $3.03M sold.

Connors Investor Services first reported a position in VIVO in Q2 2013 and held it in 24 quarters. The position peaked at $3.23M in Q2 2017. 173 funds tracked by Wall St. Rank hold VIVO as of Q2 2019.

  • Connors Investor Services reported no remaining Meridian Bioscience Inc position as of Q2 2019 after selling out during the quarter.
  • Connors Investor Services sold 172,043 Meridian Bioscience Inc shares in Q2 2019, an estimated $3.03M.
  • Connors Investor Services first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 24 quarters.
  • Connors Investor Services's Meridian Bioscience Inc position peaked at $3.23M in Q2 2017.
  • 173 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2019.

Based on Connors Investor Services's 13F filing for Q2 2019, filed 14 Aug 2019.